FBInvestor
Stocks / Achilles Therapeutics Pl-Adr
Institutional Ownership

Achilles Therapeutics Pl-Adr

CUSIP 00449L102COM698Q1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon